Boston, Aug. 25, 2026 (GLOBE NEWSWIRE) — The global veterinary medical devices market is projected to grow from $6.5 billion in 2024 to $9.1 billion by 2030, advancing at a compound annual growth rate (CAGR) of 6.1% during the 2025–2030 forecast period. These findings are detailed in BCC Research’s newly published report, Global Veterinary Medical Devices Market, which identifies pet humanization, expanding insurance coverage, and rapid device innovation as the primary forces reshaping capital allocation across the veterinary care continuum.
Key Findings
• The global veterinary medical devices market is forecast to reach $9.1 billion by 2030, growing at a 6.1% CAGR from 2025 to 2030, fueled by structural increases in companion animal populations and the parallel premiumization of veterinary care as pet owners increasingly seek human-grade diagnostic and surgical interventions for their animals.
• North America commands the largest regional share at 55.9% of the global market, underpinned by a mature veterinary infrastructure, high per-capita spending on companion animal health, and a rapidly scaling pet insurance sector — U.S. gross written premiums reached $4.7 billion in 2024 across 6.4 million insured pets — which significantly reduces price sensitivity and accelerates adoption of higher-value procedures and devices.
• Technological acceleration is a defining competitive dynamic, with AI-powered diagnostic imaging platforms, point-of-care (PoC) in vitro diagnostics delivering bench-to-bedside results within 15 minutes, and cloud-connected SaaS diagnostic platforms integrated with Practice Management Systems collectively driving clinic upgrade cycles and enabling new revenue streams for device manufacturers.
• Emerging markets across Asia-Pacific, Latin America, and the Middle East represent a meaningful long-term growth frontier, as rising disposable incomes, economic development, and expanding livestock production create addressable demand for diagnostic and health-management tools that remains significantly underpenetrated relative to developed market benchmarks.
• Next-generation innovations across multiple device categories — including AI-enabled hematology analyzers, wireless handheld point-of-care ultrasound solutions, wearable remote animal health monitoring devices, 3D-printed personalized orthopedic implants and prosthetics, veterinary regenerative medicine (platelet-rich plasma and stem cell therapy), cold plasma therapy devices, and augmented MRI solutions — are broadening the addressable opportunity and raising average selling price potential across the device ecosystem.
• The competitive landscape is led by IDEXX Laboratories Inc., Zoetis Services LLC, and Antech Diagnostics Inc., alongside Shenzhen Mindray Animal Medical Technology Co. Ltd., B. Braun Vet Care GmbH (B. Braun SE), Medtronic, ICU Medical Inc., Midmark Corp., Covetrus, and Bionet Co. Ltd.
Market Drivers
The veterinary medical devices market is being reshaped by a convergence of demand-side and supply-side structural forces. On the demand side, deepening pet humanization trends are compelling owners to pursue advanced diagnostics, imaging, and surgical interventions previously reserved for human medicine. The rapid scaling of pet insurance — particularly in North America — is a critical demand enabler: by absorbing out-of-pocket cost exposure, insurance coverage is unlocking willingness to authorize high-value procedures and premium-priced devices. Simultaneously, expanding livestock production globally and increasingly stringent food safety regulations are driving systematic adoption of diagnostic and health-management tools across the agricultural supply chain, diversifying the market beyond companion animal care.
On the supply side, device manufacturers are investing aggressively in AI-powered imaging, PoC diagnostics, and connected digital platforms that directly address the productivity and diagnostic accuracy constraints facing veterinary clinics. Telemedicine integration with connected monitoring devices is expanding the addressable service model beyond the clinic footprint, while preventive care trends and growing chronic disease management in companion animals are generating recurring, high-frequency device utilization that supports predictable revenue for both manufacturers and distributors.
Investment Considerations
Investors should evaluate the veterinary medical devices market as a structurally resilient growth category with defensive characteristics — pet healthcare spending has demonstrated relative insulation from macroeconomic softness — and meaningful upside from technology-driven ASP expansion and insurance penetration deepening. The primary risks center on capital intensity barriers facing small and mid-sized clinics, which can prolong replacement cycles and slow technology diffusion outside large corporate veterinary groups. Regulatory compliance complexity across jurisdictions adds time-to-market friction for new entrants. Companies best positioned to capture disproportionate share include those with integrated diagnostic ecosystems, established SaaS and data platform capabilities, and deep distribution relationships with corporate veterinary consolidators — attributes most evident in IDEXX Laboratories, Zoetis, and Shenzhen Mindray Animal Medical Technology.
About the Report
Global Veterinary Medical Devices Market provides comprehensive market sizing, segmentation analysis, competitive intelligence, and forecasts covering the 2025–2030 period across device categories, end markets, and geographies.
About BCC Research
BCC Research provides objective, unbiased measurement and assessment of market opportunities with detailed market research reports. Our experienced industry analysts assess growth trends, identify and evaluate new and changing market opportunities, and provide critical information and innovative decision support tools to help inform the strategic decision-making process.
For media inquiries, email press@bccresearch.com or visit our media page for access to our market research library.
Any data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher.